283 related articles for article (PubMed ID: 25749879)
1. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment.
Sosnoski DM; Norgard RJ; Grove CD; Foster SJ; Mastro AM
Clin Exp Metastasis; 2015 Apr; 32(4):335-44. PubMed ID: 25749879
[TBL] [Abstract][Full Text] [Related]
2. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
Bussard KM; Venzon DJ; Mastro AM
J Cell Biochem; 2010 Dec; 111(5):1138-48. PubMed ID: 20683902
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1).
Kajii T; Suzuki K; Yoshikawa M; Imai T; Matsumoto A; Nakamura S
Arch Oral Biol; 1999 Mar; 44(3):233-41. PubMed ID: 10217514
[TBL] [Abstract][Full Text] [Related]
4. Three-Dimensional in Vitro Model to Study Osteobiology and Osteopathology.
Krishnan V; Vogler EA; Mastro AM
J Cell Biochem; 2015 Dec; 116(12):2715-23. PubMed ID: 26039562
[TBL] [Abstract][Full Text] [Related]
5. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
[TBL] [Abstract][Full Text] [Related]
6. Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.
Tivari S; Lu H; Dasgupta T; De Lorenzo MS; Wieder R
Cell Commun Signal; 2018 Aug; 16(1):48. PubMed ID: 30119678
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid and prostaglandin E2 influence human osteoblast (MG63) response to titanium surface roughness.
Dean DD; Campbell CM; Gruwell SF; Tindall JW; Chuang HH; Zhong W; Schmitz JP; Sylvia VL
J Oral Implantol; 2008; 34(6):303-12. PubMed ID: 19133484
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
Morgan H; Tumber A; Hill PA
Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
[TBL] [Abstract][Full Text] [Related]
9. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
Lader CS; Flanagan AM
Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
Tulotta C; Lefley DV; Freeman K; Gregory WM; Hanby AM; Heath PR; Nutter F; Wilkinson JM; Spicer-Hadlington AR; Liu X; Bradbury SMJ; Hambley L; Cookson V; Allocca G; Kruithof de Julio M; Coleman RE; Brown JE; Holen I; Ottewell PD
Clin Cancer Res; 2019 May; 25(9):2769-2782. PubMed ID: 30670488
[TBL] [Abstract][Full Text] [Related]
12. Metastatic breast cancer induces an osteoblast inflammatory response.
Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
[TBL] [Abstract][Full Text] [Related]
14. Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model.
Bodenstine TM; Beck BH; Cao X; Cook LM; Ismail A; Powers SJ; Powers JK; Mastro AM; Welch DR
Chin J Cancer; 2011 Mar; 30(3):189-96. PubMed ID: 21352696
[TBL] [Abstract][Full Text] [Related]
15. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer.
Singh B; Berry JA; Vincent LE; Lucci A
J Surg Res; 2006 Jul; 134(1):44-51. PubMed ID: 16678856
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
[TBL] [Abstract][Full Text] [Related]
17. Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors.
Morinaga Y; Fujita N; Ohishi K; Zhang Y; Tsuruo T
J Cell Physiol; 1998 Jun; 175(3):247-54. PubMed ID: 9572469
[TBL] [Abstract][Full Text] [Related]
18. Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures.
Krishnan V; Shuman LA; Sosnoski DM; Dhurjati R; Vogler EA; Mastro AM
J Cell Physiol; 2011 Aug; 226(8):2150-8. PubMed ID: 21520067
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-beta and tumor cell factors.
Morinaga Y; Fujita N; Ohishi K; Tsuruo T
Int J Cancer; 1997 May; 71(3):422-8. PubMed ID: 9139879
[TBL] [Abstract][Full Text] [Related]
20. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
